More questions
More questions ( 19 Questions)
A nurse is caring for a client who has heart failure and is receiving carvedilol (Coreg). The nurse should monitor which of the following laboratory values to determine therapeutic effectiveness of this medication?
The nurse should monitor the serum potassium level to determine the therapeutic effectiveness of carvedilol (Coreg), which is a beta-blocker that can lower the heart rate and blood pressure. Carvedilol can also cause hyperkalemia, which is a high level of potassium in the blood that can lead to cardiac arrhythmias and muscle weakness. Therefore, the nurse should monitor the serum potassium level and report any values above 5.0 mEq/L to the provider.
Serum sodium level is wrong because carvedilol does not affect the sodium level significantly. Sodium level is more relevant for diuretics, which can cause hyponatremia (low sodium) or hypernatremia (high sodium) depending on the type and dose of the medication.
Serum magnesium level is wrong because carvedilol does not affect the magnesium level significantly.
Magnesium level is more relevant for digoxin, which is another medication used for heart failure that can cause hypomagnesemia (low magnesium) or hypermagnesemia (high magnesium). Hypomagnesemia can increase the risk of digoxin toxicity, while hypermagnesemia can decrease the effectiveness of digoxin.
Serum calcium level is wrong because carvedilol does not affect the calcium level significantly.
Calcium level is more relevant for calcium channel blockers, which are another class of medications used for heart failure that can lower the heart rate and blood pressure by blocking the entry of calcium into the cardiac and vascular smooth muscle cells.
Calcium channel blockers can cause hypocalcemia (low calcium) or hypercalcemia (high calcium), which can affect the cardiac contractility and conduction.
The nurse should monitor the serum potassium level to determine the therapeutic effectiveness of carvedilol (Coreg), which is a beta-blocker that can lower the heart rate and blood pressure. Carvedilol can also cause hyperkalemia, which is a high level of potassium in the blood that can lead to cardiac arrhythmias and muscle weakness. Therefore, the nurse should monitor the serum potassium level and report any values above 5.0 mEq/L to the provider.
Choice B) Serum sodium level is wrong because carvedilol does not affect the sodium level significantly. Sodium level is more relevant for diuretics, which can cause hyponatremia (low sodium) or hypernatremia (high sodium) depending on the type and dose of the medication.
Choice C) Serum magnesium level is wrong because carvedilol does not affect the magnesium level significantly.
Magnesium level is more relevant for digoxin, which is another medication used for heart failure that can cause hypomagnesemia (low magnesium) or hypermagnesemia (high magnesium). Hypomagnesemia can increase the risk of digoxin toxicity, while hypermagnesemia can decrease the effectiveness of digoxin.
Choice D) Serum calcium level is wrong because carvedilol does not affect the calcium level significantly.
Calcium level is more relevant for calcium channel blockers, which are another class of medications used for heart failure that can lower the heart rate and blood pressure by blocking the entry of calcium into the cardiac and vascular smooth muscle cells.
Calcium channel blockers can cause hypocalcemia (low calcium) or hypercalcemia (high calcium), which can affect the cardiac contractility and conduction.
The normal ranges for serum electrolytes are:
• Potassium: 3.5 to 5.0 mEq/L
• Sodium: 135 to 145 mEq/L
• Magnesium: 1.5 to 2.5 mEq/L
• Calcium: 8.5 to 10.5 mg/dL